Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

ShedRx vs Garcia Weight Loss, Aesthetics & Hormone Therapy

Two GLP-1 desks, one scoreboard. We put ShedRx and Garcia Weight Loss, Aesthetics & Hormone Therapy head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 5 · Grade B+

ShedRx

Visit ShedRx Full brief →
vs
No. 306 · Grade C

Garcia Weight Loss, Aesthetics & Hormone Therapy

Visit Garcia Weight Loss, Aesthetics & Hormone Therapy Full brief →

The verdict

ShedRx takes this head-to-head.

ShedRx scores 87 to 61 on our six-factor Brief Score — A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.

That doesn't make Garcia Weight Loss, Aesthetics & Hormone Therapy a bad call — it's best for readers who want florida residents who want an established in-person weight-loss clinic with provider-supervised glp-1 care. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
86
48
Supply Reliability
86
73
Transparency
84
48
Access Breadth
85
46
Clinical Oversight
85
79
Track Record
86
84
ShedRxBrief Score 87 · 61Garcia Weight Loss, Aesthetics & Hormone Therapy

Price, coverage & the tracker

ShedRxGarcia Weight Loss, Aesthetics & Hormone Therapy
Brief Score87/100 (B+)61/100 (C)
Semaglutide$199/moFrom $400/mo (starting dose, compounded)
Tirzepatide$299/moNot disclosed
CoverageNot disclosed1 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
On the trackerFallingprice fallingNewnew to the tracker, no prior reading

ShedRx: Competitive tirzepatide rate trimmed further this cycle — cheapest tirz among our partner desks.

Garcia Weight Loss, Aesthetics & Hormone Therapy: New to the tracker on 1 August 2026. The published line reads From $400/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.